Hershey introduces new plant-based additions to Hershey’s and Reese’s brands
As more people reach for plant-based snacks, The Hershey Company is offering two delicious options sure to satiate their appetite for a milk chocolate alternative.
Supplier News
IRI and NPD rebrand as Circana
CHICAGO – Following their merger in August 2022, Information Resources, Inc. (IRI) and The NPD Group (NPD) has unveiled a new combined company name and brand identity: Circana. Circana is the leading advisor on the complexity of consumer behavior.
HRG reviews 1,875 new items in 2022
WAUKESHA, Wis. – HRG’s new item review team, in its ongoing evaluation of products suitable for the independent pharmacy channel, examined 1,875 new health, beauty, and wellness (HBW) items in 2022. This is a decrease of 15.
Criteo acquires Brandcrush
Criteo announced its acquisition of Brandcrush, an Australia-based company whose platform enables the buying and selling of omnichannel retail media, including offline media channels.
AllianceRx Walgreens Pharmacy named again in Forbes rankings
AllianceRx Walgreens Pharmacy, one of the largest specialty and home delivery pharmacies in the U.S., has been named in Forbes magazine’s 2023 list of America’s Best Midsize Employers. This is the third consecutive year the specialty pharmacy has been honored alongside other top U.S.
imPRESS Press-On Manicure and LoveShackFancy team up
imPRESS Press-On Manicure from KISS, the world’s leader in professional quality nail products, is thrilled to unveil its latest fashion collaboration with LoveShackFancy.
Sales of chocolate, candy still strong amid inflation and supply chain issues
AVENTURA, Fla. – In 2022, confectionery category dollar sales grew 11.1% over 2021, and 22.
Abbott’s iCGM sensors are cleared for connectivity with automated insulin delivery systems in the U.S.
Abbott announced that the U.S. Food and Drug Administration (FDA) has cleared its FreeStyle Libre 2 and FreeStyle Libre 3 integrated continuous glucose monitoring (iCGM) system sensors for integration with automated insulin delivery (AID) systems.
Camber launches generic Ranexa
Camber Pharmaceuticals has added ranolazine ER tablets to its current portfolio. Ranolazine ER tablets is a prescription medicine used to treat angina that keeps coming back (chronic angina).
Eosera launches strategy reaching health care providers and celebrates World Hearing Day
In line with World Hearing Day, ear care company, Eosera, announces new strategy to reach healthcare professionals and cement EOSERA’s position as the leader in ear care by launching an internal sales force.
Cetaphi unveils digital AI skin analysis tool
Cetaphil, the dermatologist recommended sensitive skincare brand, announced today the launch of its Cetaphil AI Skin Analysis: a comprehensive skin analyzer offering personalized skin assessment scores and skincare regimen recommendations in seconds.
Queen V announces the launch of The V Files
NEW YORK– Queen V, an intimate wellness brand, announced The V Files, a surprising data-driven look into women’s feelings and attitudes toward their Vagina, particularly first experiences, and how they are affecting Gen Z and Millennials mental and emotional health and impacting daily lives.
Camber unveils generic Valcyte
PISCATAWAY, N.J. – Camber Pharmaceuticals announced the addition of valganciclovir for oral solution to its current portfolio.
CHPA Educational Foundation launches HealthInHand.org
The Consumer Healthcare Products Association’s (CHPA) Educational Foundation today announced the launch of HealthInHand.org, its rebranded online destination and go-to resource for information on self-care products. Formerly called KnowYourOTCs.
Dr Reddy’s buys US generic products portfolio of Mayne Pharma
Dr. Reddy’s Laboratories has agreed to acquire the U.S. generic prescription product portfolio of Australia-based Mayne Pharma Group Limited. Under the terms of the agreement, Dr.
Lilly cuts insulin prices by 70%
Eli Lilly and Co. announced price reductions of 70% for its most commonly prescribed insulins and an expansion of its Insulin Value Program that caps patient out-of-pocket costs at $35 or less per month.